A detailed history of Berkshire Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Berkshire Bank holds 10,235 shares of BMY stock, worth $587,693. This represents 0.14% of its overall portfolio holdings.

Number of Shares
10,235
Previous 11,064 7.49%
Holding current value
$587,693
Previous $572,000 1.05%
% of portfolio
0.14%
Previous 0.13%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

SELL
$51.92 - $59.94 $43,041 - $49,690
-829 Reduced 7.49%
10,235 $578,000
Q3 2024

Oct 18, 2024

SELL
$39.66 - $51.75 $73,846 - $96,358
-1,862 Reduced 14.41%
11,064 $572,000
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $92,977 - $122,406
-2,310 Reduced 15.16%
12,926 $536,000
Q1 2024

Apr 24, 2024

SELL
$47.98 - $54.4 $447,269 - $507,116
-9,322 Reduced 37.96%
15,236 $826,000
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $92,887 - $110,840
-1,916 Reduced 7.24%
24,558 $1.26 Million
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $521 - $582
-9 Reduced 0.03%
26,474 $1.54 Million
Q2 2023

Jul 12, 2023

SELL
$63.71 - $70.74 $142,646 - $158,386
-2,239 Reduced 7.8%
26,483 $1.69 Million
Q1 2023

Apr 11, 2023

SELL
$65.71 - $74.53 $225,648 - $255,936
-3,434 Reduced 10.68%
28,722 $1.99 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $395,951 - $468,862
-5,782 Reduced 15.24%
32,156 $2.31 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $601 - $355,692
-4,629 Reduced 10.87%
37,938 $2.7 Million
Q2 2022

Jul 15, 2022

SELL
$72.62 - $79.98 $372,104 - $409,817
-5,124 Reduced 10.74%
42,567 $3.28 Million
Q1 2022

Apr 21, 2022

SELL
$61.48 - $73.72 $168,639 - $202,213
-2,743 Reduced 5.44%
47,691 $3.48 Million
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $150,217 - $175,118
-2,801 Reduced 5.26%
50,434 $3.14 Million
Q3 2021

Oct 14, 2021

BUY
$59.17 - $69.31 $45,146 - $52,883
763 Added 1.45%
53,235 $3.15 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $149,760 - $163,088
2,419 Added 4.83%
52,472 $3.51 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $6,705 - $7,541
113 Added 0.23%
50,053 $3.16 Million
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $156,937 - $177,838
2,718 Added 5.76%
49,940 $3.1 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $2.71 Million - $3.01 Million
47,222 New
47,222 $2.85 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Berkshire Bank Portfolio

Follow Berkshire Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.